During the past decade, Streekziekenhuis Koningin Beatrix conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Streekziekenhuis Koningin Beatrix" #1 sponsor was "Borstkanker Onderzoek Groep" with 2 trials, followed by "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored, "AEterna Zentaris" with 1 trials sponsored, "Catharina Ziekenhuis Eindhoven" with 1 trials sponsored and "Comprehensive Cancer Centre The Netherlands" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Streekziekenhuis Koningin Beatrix" #1 collaborator was "Cephalon" with 2 trials as a collaborator, "Sanofi" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Central European Myeloma Study Group" with 1 trials as a collaborator and "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Streekziekenhuis Koningin Beatrix" are "Breast Cancer" (3 trials), "Neoplasm Metastasis" (2 trials), "Benign Prostatic Hypertrophy" (1 trials), "Breast Neoplasm Female" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Streekziekenhuis Koningin Beatrix" in a lesser frequency.

Most popular intervention types in "Streekziekenhuis Koningin Beatrix" are "Drug" (8 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "AT1 blocker candesartan" (1 trials) and "Bortezomib, Melphalan, Prednisone (VMP)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Streekziekenhuis Koningin Beatrix" are 6 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Streekziekenhuis Koningin Beatrix". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Streekziekenhuis Koningin Beatrix, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Streekziekenhuis Koningin Beatrix, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".